SLC16A3 and cancer: Similarly, the m6A demethylase Alkbh5 modulates Mct4/Slc16a3 expression and lactate levels in the TME, enhancing the efficacy of cancer immunotherapy by altering the composition of tumor-infiltrating Tregs and MDSCs [99].